Cargando…
Anti-SARS-CoV-2 Activity of Adamantanes In Vitro and in Animal Models of Infection
Coronavirus disease 2019 (COVID-19) has had devastating effects worldwide, with particularly high morbidity and mortality in outbreaks on residential care facilities. Amantadine, originally licensed as an antiviral agent for therapy and prophylaxis against influenza A virus, has beneficial effects o...
Autores principales: | Lim, Sun-Young, Guo, Zhiru, Liu, Ping, McKay, Lindsay G. A., Storm, Nadia, Griffiths, Anthony, Qu, Ming Da, Finberg, Robert W., Somasundaran, Mohan, Wang, Jennifer P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10238102/ https://www.ncbi.nlm.nih.gov/pubmed/37274537 http://dx.doi.org/10.3390/covid2110111 |
Ejemplares similares
-
Rapid and complete inactivation of SARS-CoV-2 by ultraviolet-C irradiation
por: Storm, Nadia, et al.
Publicado: (2020) -
Adamantanes for the treatment of neurodegenerative diseases in the presence of SARS-CoV-2
por: Butterworth, Roger F.
Publicado: (2023) -
A trimeric human angiotensin-converting enzyme 2 as an anti-SARS-CoV-2 agent
por: Xiao, Tianshu, et al.
Publicado: (2021) -
A Newly Engineered A549 Cell Line Expressing ACE2 and TMPRSS2 Is Highly Permissive to SARS-CoV-2, Including the Delta and Omicron Variants
por: Chang, Ching-Wen, et al.
Publicado: (2022) -
Electronic spectroscopy of cationic adamantane clusters and dehydrogenated adamantane in helium droplets
por: Kappe, Miriam, et al.
Publicado: (2022)